Assembly Bill A7355

2009-2010 Legislative Session

Requires coverage of orally administered chemotherapy treatments

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

2009-A7355 - Details

Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2011-2012 Legislative Session:
A6233

2009-A7355 - Summary

Requires coverage of orally administered chemotherapy treatments.

2009-A7355 - Bill Text download pdf 

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7355

                       2009-2010 Regular Sessions

                          I N  A S S E M B L Y

                             March 31, 2009
                               ___________

Introduced  by  M.  of A. V. LOPEZ, SCHROEDER, KELLNER, GUNTHER, GREENE,
  COLTON, O'DONNELL, TITONE, STIRPE, PHEFFER, SPANO  --  Multi-Sponsored
  by  --  M.  of  A.  ALESSI, BARRON, BING, BRENNAN, CAHILL, CYMBROWITZ,
  EDDINGTON, FIELDS, GALEF, GLICK, HOOPER, HYER-SPENCER,  JACOBS,  KOON,
  LANCMAN,  LUPARDO,  MAGEE,  MAISEL,  MARKEY, MAYERSOHN, McENENY, MENG,
  REILLY,  RUSSELL,  SCHIMEL,  SWEENEY,  WEISENBERG  --  read  once  and
  referred to the Committee on Insurance

AN  ACT  to  amend  the insurance law, in relation to policy coverage of
  chemotherapy treatment

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
amended by adding a new paragraph 12-a to read as follows:
  (12-A) EVERY POLICY DELIVERED OR ISSUED FOR  DELIVERY  IN  THIS  STATE
THAT  PROVIDES  MEDICAL,  MAJOR  MEDICAL,  OR SIMILAR COMPREHENSIVE-TYPE
COVERAGE AND PROVIDES COVERAGE FOR CANCER CHEMOTHERAPY  TREATMENT  SHALL
PROVIDE  COVERAGE FOR A PRESCRIBED, ORALLY ADMINISTERED ANTICANCER MEDI-
CATION USED TO KILL OR SLOW THE GROWTH OF CANCEROUS CELLS ON A BASIS  NO
LESS  FAVORABLE THAN INTRAVENOUSLY ADMINISTERED OR INJECTED CANCER MEDI-
CATIONS.
  S 2. Subsection (k) of section 3221 of the insurance law is amended by
adding a new paragraph 9-a to read as follows:
  (9-A) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED  FOR  DELIVERY
IN  THIS  STATE THAT PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR COMPRE-
HENSIVE-TYPE COVERAGE AND  PROVIDES  COVERAGE  FOR  CANCER  CHEMOTHERAPY
TREATMENT  SHALL  PROVIDE COVERAGE FOR A PRESCRIBED, ORALLY ADMINISTERED
ANTICANCER MEDICATION USED TO KILL OR SLOW THE GROWTH OF CANCEROUS CELLS
ON A BASIS NO LESS FAVORABLE THAN INTRAVENOUSLY ADMINISTERED OR INJECTED
CANCER MEDICATIONS.
  S 3. Section 4303 of the insurance law is  amended  by  adding  a  new
subsection (q-1) to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10074-02-9

co-Sponsors

multi-Sponsors

2009-A7355A - Details

Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2011-2012 Legislative Session:
A6233

2009-A7355A - Summary

Requires coverage of orally administered chemotherapy treatments.

2009-A7355A - Sponsor Memo

2009-A7355A - Bill Text download pdf 

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7355--A

                       2009-2010 Regular Sessions

                          I N  A S S E M B L Y

                             March 31, 2009
                               ___________

Introduced  by  M.  of A. V. LOPEZ, SCHROEDER, KELLNER, GUNTHER, COLTON,
  O'DONNELL, TITONE, STIRPE, PHEFFER, SPANO,  ROSENTHAL  --  Multi-Spon-
  sored  by  -- M. of A. ALESSI, BARRON, BING, BRENNAN, CAHILL, CYMBROW-
  ITZ, EDDINGTON, FIELDS, GALEF, GLICK,  HOOPER,  HYER-SPENCER,  JACOBS,
  KOON,  LANCMAN,  LUPARDO,  MAGEE,  MAISEL, MARKEY, MAYERSOHN, McENENY,
  MENG, REILLY, RUSSELL, SCHIMEL, SWEENEY, WEISENBERG -- read  once  and
  referred  to  the Committee on Insurance -- committee discharged, bill
  amended, ordered reprinted as amended and recommitted to said  commit-
  tee

AN  ACT  to  amend  the insurance law, in relation to policy coverage of
  chemotherapy treatment

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Legislative findings. The legislature finds that advances
in medical research have led to significant new developments of  various
medical  treatments. These treatments offer patients a wide range of new
choices to combat very serious diseases. The area  of  cancer  treatment
has  been  one of the fields that has seen these significant new medical
advancements. In recent years, oral chemotherapy  treatments  have  been
developed  that  provide  viable alternatives to traditional intravenous
cancer treatments for patients. This oral chemotherapy treatment  offers
the treating physician and the patient a choice in relation to treatment
options.  However, this choice is sometimes limited as the oral chemoth-
erapy treatments are, in most cases, covered under the prescription drug
benefit of an insurance plan rather than under the major medical  insur-
ance  benefit  of  an  insurance  plan. This discrepancy in coverage can
limit a patient's ability to  choose  the  oral  chemotherapy  treatment
because of the cost associated with the disparate treatment.
  S 2. Subsection (i) of section 3216 of the insurance law is amended by
adding a new paragraph 12-a to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10074-03-9

co-Sponsors

multi-Sponsors

2009-A7355B (ACTIVE) - Details

Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2011-2012 Legislative Session:
A6233

2009-A7355B (ACTIVE) - Summary

Requires coverage of orally administered chemotherapy treatments.

2009-A7355B (ACTIVE) - Bill Text download pdf 

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7355--B

                       2009-2010 Regular Sessions

                          I N  A S S E M B L Y

                             March 31, 2009
                               ___________

Introduced  by  M.  of A. V. LOPEZ, SCHROEDER, KELLNER, GUNTHER, COLTON,
  O'DONNELL, TITONE, STIRPE, PHEFFER, SPANO, ROSENTHAL, JAFFEE,  GIBSON,
  CASTRO,  N. RIVERA,  POWELL, LAVINE, PERRY -- Multi-Sponsored by -- M.
  of A.   ALESSI, BARRON, BING,  BRENNAN,  CAHILL,  CRESPO,  CYMBROWITZ,
  FIELDS,  GABRYSZAK,  GALEF, GLICK, HOOPER, HYER-SPENCER, JACOBS, KOON,
  LANCMAN, LATIMER, LIFTON, LUPARDO, MAGEE, MAISEL,  MARKEY,  MAYERSOHN,
  McENENY,  MENG, J. MILLER, PRETLOW, REILLY, RUSSELL, SCHIMEL, SWEENEY,
  TOWNS, WEISENBERG -- read once and referred to the Committee on Insur-
  ance -- committee  discharged,  bill  amended,  ordered  reprinted  as
  amended  and  recommitted  to  said  committee  --  recommitted to the
  Committee on Insurance in accordance with Assembly Rule 3, sec.  2  --
  committee  discharged,  bill amended, ordered reprinted as amended and
  recommitted to said committee

AN ACT to amend the insurance law, in relation  to  policy  coverage  of
  chemotherapy treatment

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Legislative findings. The legislature finds  that  advances
in  medical research have led to significant new developments of various
medical treatments. These treatments offer patients a wide range of  new
choices  to  combat  very serious diseases. The area of cancer treatment
has been one of the fields that has seen these significant  new  medical
advancements.  In  recent  years, oral chemotherapy treatments have been
developed that provide viable alternatives  to  traditional  intravenous
cancer  treatments for patients. This oral chemotherapy treatment offers
the treating physician and the patient a choice in relation to treatment
options. However, this choice is sometimes limited as the oral  chemoth-
erapy treatments are, in most cases, covered under the prescription drug
benefit  of an insurance plan rather than under the major medical insur-
ance benefit of an insurance plan.  This  discrepancy  in  coverage  can

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10074-06-0

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.